Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-218501
Filing Date
2024-09-13
Accepted
2024-09-13 09:12:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d840082d424b3.htm 424B3 26081
2 GRAPHIC g840082g0913165956012.jpg GRAPHIC 3832
3 GRAPHIC g840862dsp4.jpg GRAPHIC 5430
  Complete submission text file 0001193125-24-218501.txt   40326
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 241296574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)